HomeCVKD • NASDAQ
add
Cadrenal Therapeutics Inc
Previous close
$8.25
Day range
$7.83 - $8.91
Year range
$7.45 - $22.90
Market cap
16.85M USD
Avg Volume
49.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.73M | 11.13% |
Net income | -2.69M | -11.54% |
Net profit margin | — | — |
Earnings per share | -1.31 | 39.91% |
EBITDA | -2.73M | -11.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.86M | -11.55% |
Total assets | 4.09M | -12.64% |
Total liabilities | 1.35M | 6.77% |
Total equity | 2.73M | — |
Shares outstanding | 2.08M | — |
Price to book | 6.20 | — |
Return on assets | -135.79% | — |
Return on capital | -194.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.69M | -11.54% |
Cash from operations | -2.36M | -7.08% |
Cash from investing | -1.85K | — |
Cash from financing | 648.36K | -57.57% |
Net change in cash | -1.71M | -154.08% |
Free cash flow | -1.38M | -3.84% |
About
Founded
2022
Website
Employees
4
